Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraße 31, D-93053 Regensburg, Germany.
J Med Chem. 2023 Oct 12;66(19):13788-13808. doi: 10.1021/acs.jmedchem.3c01224. Epub 2023 Sep 29.
The family of human neuropeptide Y receptors (YRs) comprises four subtypes (YR, YR, YR, and YR) that are involved in the regulation of numerous physiological processes. Until now, YR binding studies have been predominantly performed in hypotonic sodium-free buffers using I-labeled derivatives of the endogenous YR agonists pancreatic polypeptide or peptide YY. A few tritium-labeled YR ligands have been reported; however, when used in buffers containing sodium at a physiological concentration, their YR affinities are insufficient. Based on the cyclic hexapeptide UR-AK86C, we developed a new tritium-labeled YR radioligand ([H]UR-JG102, [H]). In sodium-free buffer, [H] exhibits a very low YR dissociation constant ( 0.012 nM). In sodium-containing buffer (137 mM Na), the YR affinity is lower ( 0.11 nM) but still considerably higher compared to previously reported tritiated YR ligands. Therefore, [H] represents a useful tool compound for the determination of YR binding affinities under physiological-like conditions.
人类神经肽 Y 受体(YRs)家族由四个亚型(YR、YR、YR 和 YR)组成,它们参与了许多生理过程的调节。到目前为止,YR 结合研究主要是在低渗无钠缓冲液中使用 I 标记的内源性 YR 激动剂胰多肽或肽 YY 的衍生物进行的。已经报道了一些氚标记的 YR 配体;然而,当在含有生理浓度钠的缓冲液中使用时,它们对 YR 的亲和力不足。基于环状六肽 UR-AK86C,我们开发了一种新的氚标记的 YR 放射性配体 ([H]UR-JG102,[H])。在无钠缓冲液中,[H]的 YR 解离常数非常低(0.012 nM)。在含钠缓冲液(137 mM Na)中,YR 的亲和力较低(0.11 nM),但与之前报道的氚标记 YR 配体相比仍然高得多。因此,[H]是在类似生理条件下测定 YR 结合亲和力的有用工具化合物。